Use of 15-lipoxygenase inhibitors for treating and preventing bone loss
Details for Australian Patent Application No. 2003206822 (hide)
International Classifications
Event Publications
17 July 2003 Complete Application Filed
Priority application(s): 60/355,255 08.02.02 US
25 September 2003 Application Open to Public Inspection
Published as AU-B-2003206822
29 May 2008 Application Accepted
Published as AU-B-2003206822
4 September 2008 Application for Amendment
The nature of the amendment is as shown in the statement(s) filed 30 Jun 2008. Address for service in Australia - Spruson & Ferguson Level 35 St Martins Tower 31 Market Street Sydney NSW 2000
25 September 2008 Standard Patent Sealed
22 January 2009 Amendment Made
The nature of the amendment is as shown in the statement(s) filed 30 Jun 2008
1 September 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired
This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
- Editable Word format reports
- For IP Professionals
- Multiuser